Operating Expenses Summary of Valneva SE

Valneva SE's latest annual operating expenses in 2023 was 134.92 Million EUR , up 1.54% from previous year.
Valneva SE's latest quarterly operating expenses in 2024 Q1 was 36.13 Million EUR , down -20.13% from previous quarter.
Valneva SE reported a annual operating expenses of 150.3 Million EUR in annual operating expenses 2022, down -32.16% from previous year.
Valneva SE reported a annual operating expenses of 221.55 Million EUR in annual operating expenses 2021, up 99.37% from previous year.
Valneva SE reported a quarterly operating expenses of 39.57 Million EUR for 2024 Q2, up 0.01% from previous quarter.
Valneva SE reported a quarterly operating expenses of 39.38 Million EUR for 2023 Q3, up 56.31% from previous quarter.

Annual Operating Expenses Chart of Valneva SE (2023 - 2005)

Historical Annual Operating Expenses of Valneva SE (2023 - 2005)

Year	Operating Expenses	Operating Expenses Growth
2023	134.92 Million EUR	1.54%
2022	150.3 Million EUR	-32.16%
2021	221.55 Million EUR	99.37%
2020	111.12 Million EUR	44.42%
2019	76.94 Million EUR	21.49%
2018	63.33 Million EUR	0.11%
2017	63.26 Million EUR	-32.29%
2016	93.43 Million EUR	81.9%
2015	51.36 Million EUR	17.98%
2014	43.53 Million EUR	20.75%
2013	36.05 Million EUR	121.67%
2012	16.26 Million EUR	88.09%
2011	8.64 Million EUR	-48.57%
2010	16.81 Million EUR	397.1%
2009	3.38 Million EUR	-11.63%
2008	3.82 Million EUR	-3.55%
2007	3.96 Million EUR	117.54%
2006	1.82 Million EUR	-54.01%
2005	3.96 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	36.13 Million EUR	-20.13%
2024 Q2	39.57 Million EUR	0.01%
2023 Q3	39.38 Million EUR	56.31%
2023 Q1	29.6 Million EUR	-35.7%
2023 Q4	45.24 Million EUR	14.86%
2023 Q2	25.19 Million EUR	-14.87%
2023 FY	152.62 Million EUR	1.54%
2022 Q2	45.69 Million EUR	73.04%
2022 FY	150.3 Million EUR	-32.16%
2022 Q4	46.03 Million EUR	43.14%
2022 Q3	32.16 Million EUR	-29.62%
2022 Q1	26.4 Million EUR	-64.16%
2021 Q2	59.17 Million EUR	49.03%
2021 Q1	39.7 Million EUR	13.67%
2021 FY	221.55 Million EUR	99.37%
2021 Q3	48.99 Million EUR	-17.2%
2021 Q4	73.69 Million EUR	50.42%
2020 Q3	27.51 Million EUR	7.29%
2020 FY	111.12 Million EUR	44.42%
2020 Q2	25.64 Million EUR	11.26%
2020 Q1	23.04 Million EUR	-10.37%
2020 Q4	34.93 Million EUR	26.97%
2019 Q2	16.74 Million EUR	1.95%
2019 FY	76.94 Million EUR	21.49%
2019 Q4	25.71 Million EUR	42.3%
2019 Q3	18.07 Million EUR	7.93%
2019 Q1	16.42 Million EUR	-9.68%
2018 Q2	16.83 Million EUR	6.26%
2018 Q1	15.84 Million EUR	-16.14%
2018 FY	63.33 Million EUR	0.11%
2018 Q4	18.18 Million EUR	45.65%
2018 Q3	12.48 Million EUR	-25.83%
2017 Q2	12.95 Million EUR	-11.54%
2017 Q4	18.88 Million EUR	12.6%
2017 Q3	16.77 Million EUR	29.48%
2017 FY	63.26 Million EUR	-32.29%
2017 Q1	14.64 Million EUR	-10.16%
2016 Q4	16.3 Million EUR	15.4%
2016 FY	93.43 Million EUR	81.9%
2016 Q3	14.12 Million EUR	-71.43%
2016 Q2	49.45 Million EUR	265.05%
2016 Q1	13.54 Million EUR	-5.63%
2015 Q2	14.49 Million EUR	40.46%
2015 Q1	10.31 Million EUR	-27.8%
2015 FY	51.36 Million EUR	17.98%
2015 Q4	14.35 Million EUR	17.64%
2015 Q3	12.2 Million EUR	-15.79%
2014 Q3	7.84 Million EUR	-28.87%
2014 FY	43.53 Million EUR	20.75%
2014 Q1	10.37 Million EUR	41.11%
2014 Q2	11.02 Million EUR	6.35%
2014 Q4	14.28 Million EUR	82.14%
2013 Q3	16.8 Million EUR	98.42%
2013 Q4	7.34 Million EUR	-56.28%
2013 FY	36.05 Million EUR	121.67%
2013 Q1	3.16 Million EUR	-29.28%
2013 Q2	8.47 Million EUR	167.98%
2012 Q3	3.44 Million EUR	0.0%
2012 Q4	4.47 Million EUR	29.83%
2012 FY	16.26 Million EUR	88.09%
2011 FY	8.64 Million EUR	-48.57%
2010 FY	16.81 Million EUR	397.1%
2009 FY	3.38 Million EUR	-11.63%
2008 FY	3.82 Million EUR	-3.55%
2007 FY	3.96 Million EUR	117.54%
2006 FY	1.82 Million EUR	-54.01%
2005 FY	3.96 Million EUR	0.0%

Peer Operating Expenses Comparison of Valneva SE

Name	Operating Expenses	Operating Expenses Difference
Boiron SA	317.27 Million EUR	57.474%
Laboratorios Farmaceuticos Rovi, S.A.	263.09 Million EUR	48.716%
Vetoquinol SA	217.11 Million EUR	37.856%
AB Science S.A.	14.01 Million EUR	-862.643%
Nanobiotix S.A.	62.98 Million EUR	-114.209%
PHAXIAM Therapeutics S.A.	24.98 Million EUR	-439.998%
Vivoryon Therapeutics N.V.	24.69 Million EUR	-446.428%
BioSenic S.A.	7.58 Million EUR	-1679.296%
ABIVAX Société Anonyme	127.37 Million EUR	-5.926%
Formycon AG	23.73 Million EUR	-468.508%

Global Stocks Search

Valneva SE (0OB3.L)

Operating Expenses Summary of Valneva SE

Annual Operating Expenses Chart of Valneva SE (2023 - 2005)

Historical Annual Operating Expenses of Valneva SE (2023 - 2005)

Peer Operating Expenses Comparison of Valneva SE